Clik here to view.
Enigma Biomedical Group Forms Australian Subsidiary To Further Research Efforts
TORONTO Enigma Biomedical Group today announced the formation of Enigma Biomedical Australia to support it’s ongoing research projects in Australia. The current research projects are for studies of...
View ArticleClik here to view.
Ferring and the Chinese Academy of Sciences Collaborate to Advance Research...
SAINT-PREX, Switzerland Ferring Pharmaceuticals and the Chinese Academy of Sciences (CAS) today announced a long-term collaboration to advance basic and translational research in reproductive...
View ArticleClik here to view.
Shiseido Acquires Breakthrough Technology from Olivo Laboratories
TOKYO & NEW YORK Shiseido Company, Limited (TOKYO:4911) (“Shiseido”), a leading global cosmetics company, announced today that its regional headquarters and consolidated subsidiary, Shiseido...
View ArticleClik here to view.
PeptiDream Announces the Appointment of Dr. Kiyofumi Kaneshiro to the...
KAWASAKI, Japan PeptiDream Inc., a Kanagawa-based biopharmaceutical company (“PeptiDream”)(TOKYO:4587) announced today, the appointment of Dr. Kiyofumi Kaneshiro to the management team at...
View ArticleClik here to view.
资生堂收购Olivo Laboratories，获得突破性技术
东京及纽约 (美国商业资讯)–全球领先的化妆品公司资生堂株式会社(TOKYO:4911)（简称“资生堂”）今天宣布其地区总部及合并子公司资生堂美洲公司（Shiseido Americas Corporation，简称“资生堂美洲”）已基本收购Olivo Laboratories, LLC（简称“Olivo”）的全部资产。Olivo是由Polaris...
View ArticleClik here to view.
AvantGen and Tanabe Research Laboratories Expand Collaboration for...
SAN DIEGO AvantGen, Inc., a privately-held antibody discovery and optimization service provider, today announced the successful completion of a first cancer therapeutic antibody discovery program...
View ArticleClik here to view.
AvantGen与Tanabe Research Laboratories扩大在抗体治疗药物发现领域的合作
圣迭戈 (美国商业资讯) — AvantGen, Inc.是位于美国圣迭戈的一家拥有抗体发现及优化平台的生物技术公司。该公司今天宣布成功完成了Tanabe Research Laboratories USA, Inc. (TRL) 的首个抗体类抗癌药发现项目，并已启动TRL的第二个项目。...
View ArticleClik here to view.
AvantGenとタナベ リサーチ ラボラトリーズが治療用抗体の創薬に向け提携拡大
サンディエゴ （ビジネスワイヤ） — 抗体の創薬／最適化サービスを提供する非上場企業のAvantGen, Inc.は本日、タナベ リサーチ ラボラトリーズ アメリカ インク（TRL）向けの最初のがん治療用抗体創薬プログラムを成功裏に完了し、2件目のプログラムに着手したと発表しました。...
View ArticleClik here to view.
Premas, IncellDx Ink India Distribution Agreement
NEW DELHI Premas Life Sciences Pvt., Ltd. and IncellDx, Inc. announced today they have signed an exclusive distribution agreement. The commercial partnership brings the power of cell by cell...
View ArticleClik here to view.
Orthocell Secures New Patent for Suture-Less Repair of Soft Tissue
PERTH, Australia Regenerative medicine company Orthocell Limited (ASX:OCC, “Orthocell” or the “Company”) is pleased to announce it has been granted a further Australian patent for its CelGro®...
View ArticleClik here to view.
Clik here to view.
Clik here to view.
PremasとIncellDxがインドでの販売契約を締結
ニューデリー （ビジネスワイヤ） — Premas Life Sciences Pvt., Ltd.とIncellDx,...
View ArticleClik here to view.
Premas与IncellDx签署印度经销协议
新德里 (美国商业资讯) — Premas Life Sciences Pvt., Ltd.与IncellDx, Inc.今天宣布签署一份排他性经销协议。该商业伙伴关系提供了单细胞多份诊断试剂的功效，现在可采用流式细胞计数仪，分析实体瘤癌症的分子及蛋白质标记。协议内容包括：IncellDx的专利单细胞检测，用于肿瘤细胞和免疫细胞亚型上PD-L1的定量；专利单细胞检测，用于检测宫颈样本中的HPV...
View ArticleClik here to view.
Changes in Executive Management at Sosei
TOKYO & LONDON Sosei Group Corporation (“Sosei” or the “Company”) (TOKYO: 4565), the world leader in GPCR medicine design and development, today announced that Dr. Fiona Marshall has resigned...
View ArticleClik here to view.
SymBio Pharmaceuticals: Initiation of Phase I Clinical Trial for Oral...
TOKYO SymBio Pharmaceuticals Limited (Headquarters: Tokyo, “SymBio”) (JASDAQ: 4582) announced today that it has initiated a Phase 1 study in Japan for oral TREAKISYM® in patients with progressive...
View ArticleClik here to view.
シンバイオ製薬：進行性固形がんを対象としたトレアキシン®経口剤の第Ⅰ相臨床試験の開始のお知らせ
東京 （ビジネスワイヤ） — シンバイオ製薬株式会社（本社：東京都、以下「シンバイオ」） (JASDAQ: 4582) は、この度、トレアキシン®経口剤の開発について、進行性固形がんを対象とした第Ⅰ相臨床試験（以下「本試験」）を開始したことをお知らせします。...
View ArticleClik here to view.
Korean Urologist Dr. Dori Kim Got Praises for SVF Applied ‘SST phalloplasty’
SEOUL, South Korea Stantop Urology Clinic, located in Gangman, Seoul, announced that allogenic derma applied SST phalloplasty developed by its representative doctor Dori Kim is getting praises from...
View ArticleClik here to view.
Harbour BioMed Completes Series A+ Round Financing to Accelerate the...
SHANGHAI & ROTTERDAM, The Netherlands & CAMBRIDGE, Mass. Harbour BioMed announced today that it has completed a Series A+ round financing to accelerate its growth, especially the development...
View ArticleClik here to view.
European Commission Approves ADCETRIS® (brentuximab vedotin) for...
Smart Multimedia Gallery ビデオタイトル QuickTimeで再生 WindowsMediaで再生 CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Commission (EC)...
View Article